Skip to content
Tutorials Center
My learning

Topics

Lesson 32 of 48 ยท Central Nervous System Drugs

Chapter 6 review: central nervous system drugs

Review chapter 6 with a one-picture summary, a table of CNS drug targets and risks, drug-name stems, a matching game and ten mixed questions.

Brain-acting drugs look bewildering as a list of names, but they fall into a handful of patterns. Each one binds a receptor, channel, transporter or enzyme in a pathway that uses one of the four main messengers, and most side effects come from the same mechanism acting in a different part of the nervous system or body. This review gathers the chapter into a single page and then tests it.

Four cards summarizing pain and anesthesia drugs, mood and psychosis drugs, antiseizure drugs and Parkinson drugs, with a banner that most CNS drugs change dopamine, serotonin, GABA or glutamate
Chapter 6 in one picture: four therapeutic areas, one set of messengers.

What you will learn

  • Recall the main targets, uses and risks of the drug groups in this chapter.
  • Read drug-name stems to guess a drug's class.
  • Apply the four-messenger framework to a drug you have not met before.

The chapter in a table

Group Target Examples Used for Key risk
NSAIDs COX-1 and COX-2 ibuprofen, naproxen pain, inflammation, fever stomach bleeding, kidney injury
Paracetamol central COX and others acetaminophen pain, fever liver damage in overdose
Opioids mu receptor morphine, fentanyl severe pain respiratory depression, dependence
Local anesthetics sodium channels lidocaine, bupivacaine numbing a region systemic toxicity
General anesthetics GABA-A, NMDA propofol, sevoflurane, ketamine surgery breathing and circulation depressed
SSRIs serotonin transporter fluoxetine, sertraline depression, anxiety sexual effects, serotonin syndrome
Antipsychotics D2 receptor haloperidol, olanzapine psychosis movement, metabolic effects
Benzodiazepines GABA-A diazepam, lorazepam acute anxiety, seizures dependence, falls, with opioids
Lithium uncertain (GSK-3, inositol) lithium carbonate bipolar disorder narrow range, kidney and thyroid
Sodium channel blockers Naโบ channels phenytoin, carbamazepine focal seizures saturation, enzyme induction, rash
Levodopa + carbidopa dopamine replacement Sinemet-type tablets Parkinson disease wearing-off, dyskinesia

Four questions to ask about any CNS drug

When you meet a new drug, you can predict much about it with four questions.

  1. Which messenger does it change, and in which direction? A drug that increases GABA or reduces glutamate tends to sedate. One that raises dopamine tends to stimulate or to relieve parkinsonism, and one that blocks dopamine can cause movement problems.
  2. Does it get into the brain, and how fast? Lipid-soluble drugs act within minutes, and those that need transporters or pumps can have a restricted effect. Speed also shapes dependence risk: fast-acting drugs are generally more reinforcing.
  3. What is its margin of safety? A narrow therapeutic index, as with lithium and phenytoin, calls for blood tests and attention to interactions.
  4. What happens when it stops? Dependence and withdrawal are predictable for opioids, benzodiazepines and some antidepressants, and anti-seizure drugs should not be stopped abruptly.

Putting it together

Try the four questions on two drugs from the chapter. Diazepam: it enhances GABA, an inhibitory messenger, so it calms and relaxes. It is lipid-soluble and crosses the barrier within minutes, which is why intravenous diazepam can stop a seizure quickly. Its margin is wide alone but narrow with opioids or alcohol, and the nervous system adapts to it, so stopping after long use needs a taper. Phenytoin: it blocks sodium channels in a use-dependent way, so it quiets fast firing. It enters the brain easily, but its liver metabolism saturates, so the margin between a useful and a toxic dose is narrow and small dose changes matter. It also induces enzymes, which brings in interactions. Two drugs, four questions, and most of what a clinician needs to remember falls out of the answers.

Common misconceptions

"A drug that sedates is a drug that treats anxiety." Sedation and anxiety relief overlap but are different. Long-term anxiety treatment often relies on SSRIs and therapy, not on sedatives.

"Naloxone is enough after an overdose." Naloxone can wear off before the opioid does, so a person can relapse into respiratory depression. Emergency help must still be called.

"If a drug is a prodrug, a bigger dose is better." Prodrugs such as codeine and clopidogrel depend on liver enzymes, and genetic variation can make them useless in some people and dangerous in others.

Try it

First, a drug-name stem decoder for this chapter. Stems are agreed internationally and give a fast hint of a drug's class. Some names are exceptions, so use them as a clue, not as proof.

Python CNS drug-name stem decoder

Press Run (or Ctrl + Enter) to see the result here.

Program input ยท what you'd type while the program runs

Type the answers before you press Run, one per line. Each time the program reads a line (with input()), it gets the next line from this box.

Second, a matching game. A drug name appears and you choose its main target. It is a revision tool with a small set of drugs.

Match the drug to its target

Check your understanding

Quick check ยท 10 questions

of 10 answered You scored / 10 ยท perfect!

  1. 1. Which receptor is the main target of morphine?

    Mu receptors mediate most analgesia and also respiratory depression.
  2. 2. A person is given naloxone for an opioid overdose and wakes up. Why should they still be observed?

    Naloxone lasts roughly 30 to 90 minutes, which can be shorter than the opioid's action.
  3. 3. Which pair correctly matches a drug and its mechanism?

    Benzodiazepines are positive allosteric modulators of GABA-A.
  4. 4. Which problem is most associated with long-term use of first-generation antipsychotics?

    Chronic D2 blockade in movement circuits can cause late-onset abnormal movements.
  5. 5. What is the effect of carbidopa when combined with levodopa?

    Carbidopa does not cross the barrier, so brain dopamine production continues while peripheral side effects fall.
  6. 6. Which drug has strongly saturable (zero-order) kinetics at ordinary doses?

    Phenytoin metabolism saturates, so small dose increases can produce large level rises.
  7. 7. Which drug raises lithium levels the most when added?

    Thiazides reduce sodium and lithium clearance by the kidney.
  8. 8. The stem -azepam suggests which class?

    Diazepam, lorazepam and temazepam are examples.
  9. 9. Which statement about paracetamol overdose is correct?

    The toxic metabolite NAPQI damages the liver when glutathione is depleted; N-acetylcysteine is the antidote.
  10. 10. Antidepressant benefit usually appears after weeks even though monoamine levels rise within hours. What does this suggest?

    The delay is one reason the simple monoamine deficiency picture is considered incomplete.

Summary

  • Four messengers, glutamate, GABA, dopamine and serotonin, organize CNS pharmacology.
  • Pain drugs act along the pathway: COX in tissue, sodium channels in nerves, mu receptors in cord and brain, GABA-A and NMDA for anesthesia.
  • Mood and psychosis drugs act on monoamine synapses and GABA-A; antiseizure drugs quiet firing; Parkinson drugs replace or protect dopamine.
  • Ask four questions about any CNS drug: which messenger, can it reach the brain, how wide is the safety margin, and what happens when it stops.

Next: Chapter 7 overview: anti-infective and cancer drugs